Seo, Dahun https://orcid.org/0009-0002-6453-1866
Do, Anh N.
Heo, Gyujin https://orcid.org/0000-0003-3499-2848
Kwon, Jiseon
Song, Soomin https://orcid.org/0009-0003-3201-6031
Apio, Catherine
Lee, Cheolmin Matthew
Timsina, Jigyasha https://orcid.org/0000-0003-4794-9187
Gong, Katherine https://orcid.org/0009-0008-7614-9545
Chen, Yike https://orcid.org/0009-0003-9181-8608
Liu, Menghan https://orcid.org/0009-0008-9902-5983
Kohlfeld, Pat
Budde, John https://orcid.org/0000-0001-7778-7276
Boada, Merce
Orellana, Adelina
Fernandez, Maria Victoria
Ruiz, Agustin
Morris, John C.
Schindler, Suzanne E. https://orcid.org/0000-0002-1680-1465
Ibanez, Laura
Park, Taesung
Cruchaga, Carlos https://orcid.org/0000-0002-0276-2899
Sung, Yun Ju https://orcid.org/0000-0002-8021-4070
Article History
Received: 3 March 2024
Accepted: 21 August 2025
First Online: 14 October 2025
Competing interests
: C.C. has received research support from GSK and Eisai. C.C. is a member of the advisory board of Circular Genomics and owns stocks. S.E.S. has served on scientific advisory boards on biomarker testing and education for Eisai and Novo Nordisk, and has received speaking fees for presentations on biomarker testing from Eisai, Eli Lilly and Company and Novo Nordisk. The other authors declare no competing interests. The study funders had no role in the collection, analysis or interpretation of the data, the writing of the manuscript, or the decision to submit the manuscript for publication.